|
Analysis of cell-free DNA (cfDNA) fragmentomes and prediction scores across distinct molecular subtypes. |
|
|
No Relationships to Disclose |
|
|
Employment - Delfi Diagnostics |
Stock and Other Ownership Interests - Delfi Diagnostics |
|
Consulting or Advisory Role - Merck |
Patents, Royalties, Other Intellectual Property - Delfi Diagnostics |
Travel, Accommodations, Expenses - Delfi Diagnostics |
|
|
Employment - Delfi Diagnostics; Natera |
Stock and Other Ownership Interests - Delfi Diagnostics; Natera |
|
|
Employment - Delfi Diagnostics |
Stock and Other Ownership Interests - Delfi Diagnostics |
|
|
Employment - Delfi Diagnostics; Tempus |
|
|
Employment - Delfi Diagnostics; GRAIL |
Stock and Other Ownership Interests - Delfi Diagnostics; GRAIL; Illumina |
Travel, Accommodations, Expenses - Delfi Diagnostics; GRAIL |
|
|
Employment - Delfi Diagnostics |
Stock and Other Ownership Interests - Delfi Diagnostics |
Travel, Accommodations, Expenses - Delfi Diagnostics |
|
|
Stock and Other Ownership Interests - Illumina |
|
|
Employment - Delfi Diagnostics |
Stock and Other Ownership Interests - Delfi Diagnostics |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Delfi Diagnostics |
Consulting or Advisory Role - Delfi Diagnostics |
Research Funding - Delfi Diagnostics (Inst) |
Patents, Royalties, Other Intellectual Property - Cell-free DNA fragmentation in patients with cancer (Inst) |
|
|
Employment - Delfi Diagnostics |
Leadership - Delfi Diagnostics |
Stock and Other Ownership Interests - Delfi Diagnostics; Epitope Diagnostics; Viron Therapeutics |
Consulting or Advisory Role - Delfi Diagnostics |
Research Funding - Delfi Diagnostics |
Patents, Royalties, Other Intellectual Property - Agios; Delfi Diagnostics; Esoterix; Genzyme; LabCorp; ManaT Bio; Qiagen; Sysmex; Ventana Medical Systems |
|
|
Consulting or Advisory Role - Amgen; Bayer; Lilly O. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech |
Research Funding - AstraZeneca; Bristol-Myers Squibb; Novartis; Roche/Genentech |
Patents, Royalties, Other Intellectual Property - AstraZeneca; Merck; Novartis; Pfizer; Roche/Genentech |